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Prolactin (PRL) is a protein hormone secreted by the anterior pituitary in vertebrates and possesses physiological functions of remarkable diversity, including effects on reproduction, lactation and growth. PRL belongs to a family of homologous proteins comprising PRL, growth hormone (GH) and placental lactogen (PL). The biological effects associated with this cytokine family are mediated by two distinct classes of cell surface receptors, the PRL receptors (PRLR) and the GH receptors (GHR). The PRL/PL/GH biology is governed by a delicate balance between receptor crossreactivity and selectivity; PRL and PL bind selectively to PRLR, whereas GH is capable of binding both PRLR and GHR.
After being proposed for more than a decade ago (1), hormone-induced receptor dimerization became generally accepted as the model for cytokine receptor activation. For the PRL family members the model describes the signaling molecular entity as a ternary complex between one hormone molecule and a receptor homo-dimer assembled in a strictly sequential and hormone dependent fashion: first the hormone ligand engages via binding site 1 (BS1) in high affinity binding to one receptor chain forming a 1:1 hormone/receptor complex. This complex constitutes the template for binding a second, identical receptor molecule via binding site 2 (BS2) resulting in the active 1:2 complex. However, the model has been challenged by an increasing body of experimental evidence, initially reported for the homologous human erythropoietin receptor (EPOR) (2) and later for GHR (3) and PRLR (4) . These studies support that preformed, inactive dimers exist in the absence of hormone. Thus, receptor dimerization is a necessary, but not sufficient, event for receptor activation and, notably, not strictly ligand dependent. For both EPOR (5) and GHR (3) mechanistic models have been proposed, where receptor activation involves relative rotations and movements of receptor subunits induced by hormone binding. Allosteric reorganization of the intracellular receptor domains brings associated JAK2 kinases in to close proximity allowing their activation by cross-phosphorylation. This initial activation step triggers a cascade of molecular events leading to the functional receptor response (6) .
The receptor activation mechanism involving two distinct binding sites on the hormone forms the functional basis of a class of antagonists which are characterized by possessing high BS1 and impaired BS2 binding affinities. Such molecules will occupy the receptor by forming 1:1 complexes via BS1, but fail to elicit a functional response which requires productive interactions between BS2 and the second receptor chain. Examples of such antagonists forming hormone-receptor complexes with a 1:1 stoichiometry are GH-G120R (7) and the corresponding PRL-analogue, PRL-G129R (8) . As wild-type (wt) PRL is able to stimulate proliferation of tumor cells, molecules capable of antagonizing the effect of wtPRL are potentially anti-cancer agents (9) and have received considerable attention.
Detailed structural information about the interaction between GH and the extra cellular domain (ECD) of its receptor has been available since 1992, where Somers et al. (10) reported the X-ray structure of the 1:2 complex between GH and GHR-ECD, providing evidence for the receptor activation mechanism involving a ternary complex between one hormone and two receptor molecules. Subsequently, several experimentally determined structures of GH and variants thereof, both free and in complex with receptor molecules, have been reported. This abundant structural information has formed the basis for the successful rational design of GH analogues with desired properties, including antagonists and super-agonists (11) . The ensemble of published GH complex structures includes a crystal structure of a BS2 inhibited variant (GH-G120R) in a 1:1 complex with PRLR-ECD (12) . The only other structure in the protein data bank (PDB) including PRLR derived molecules is that of the complex between ovine PL (oPL) and two molecules of the extracellular domain of the rat PRLR (13). Corresponding 1:1 or 1:2 complex structures of the PRL/PRLR system have not been reported, and experimental structures of free PRL molecules became available only quite recently. The NMR derived solution structure of wtPRL (14;15) and the recently published X-ray structure of a PRLR antagonist, ∆1-9-PRL-G129R (16), represent major contributions to the structural characterization of the PRL molecule.
Due to the limited structural characterization of the PRL/PRLR-system, design of improved PRLR antagonists has relied on homology models of the hPRL/PRLR complex, built using the available GH and PL complex structures as templates. The present characterization of the PRL/PRLE-ECD complexes is a significant contribution to the molecular description of the interaction between PRL and PRLR, with the crystal structure serving as an important tool in the design and development of novel PRLmolecules.
Materials and Methods

Expression and purification of wtPRL, PRL variants and PRLR-ECD.
In addition to wtPRL two PRL variants, PRLv1 and PRLv2, were produced for HX-MS, NMR and X-ray studies: PRLv1 (Met-PRL(1-199) G129R) and PRLv2 (PRL(12-199) Q12S G129R). PRLv3 (PRL (10-199) C11S G129R) refers to the variant crystallized by Jomain et al. (16) . PRLR-ECD refers to Ser-hPRLR(1-210). Proteins were produced in E. coli as inclusion bodies, refolded and purified by standard methods (supplementary material). Proteins were characterized by various analytical methods including reversed phase HPLC, MS, tryptic digest and further analyzed for the presence of dimers using SDS-PAGE (reduced and nonreduced) and size-exclusion HPLC. The presence of deamidation species was measured by isoelectric focusing gels and ion exchange HPLC.
Hydrogen exchange mass spectrometry (HX-MS).
Buffer change and concentration in HX-MS and NMR experiments were conducted using Amicon Ultra centrifugal filter devices (Cut-off 10,000 Da, Millipore PRLv2 in the absence or  presence of PRLR-ECD into deuterated buffer  (20 mM Tris, 150 mM NaCl, 99% 2 H 2 O, pH 7.4). All exchange reactions were carried out at 30 °C and contained 6 µM PRLv2 in the absence or presence of 12 µM PRLR-ECD. At appropriate time intervals, aliquots of the exchange reaction were quenched by addition of an equal volume of ice-cold quenching buffer (1.25 M Tris(2-carboxyethyl)phosphine hydrochloride, adjusted to pH 2.0 using NaOH) resulting in a final pH of 2.5.
Quenched samples were run on a cooled HPLC-mass spectrometry system for rapid desalting and mass analysis as described previously (17) . Peptic peptides were identified in separate experiments using standard MS/MS methods on a Q-TOF2 instrument (Waters Inc.). The hydrogen exchange time-course of 27 peptides, covering 90% of the primary sequence of PRLv2, was monitored. Average masses of peptide isotopic envelopes were determined from lockmass-corrected centroided data (processed using MassLynx software, Waters Inc.). Complete deuteration of control samples was achieved by incubation for 6 hrs at 90 °C. Average back-exchange (i.e. deuterium loss) was measured to be approx. 15-20% for the analyzed peptides. However, as only the relative levels of deuterium incorporation was compared for all samples, no correction was made for this deuterium loss. N-edited 3D-NOESY-HSQC, 3D-HNCO, 3D-HNCA, 3D-HNCOCA, 3D-HNCACB and 3D-HNCOCACB spectra were recorded using standard Bruker pulse sequences. Cross-saturation experiments were recorded essentially as described previously (18) .
X-ray crystallography. The 1:1 complex between PRLv2 and PRLR-ECD was prepared and purified as described above for preparation of the PRLv1 complex for NMR studies followed by concentration to 9.5 mg/ml (2 mM ammonium bicarbonate, pH 7.9). The PRLv2/PRLR-ECD complex was crystallized by the hanging drop method at 22 ºC using a precipitant solution containing 3.5 M NaCl and 0.1 M Hepes buffer, pH 7.5. Hexagonally shaped crystals appeared in a few days and grew to dimensions of ~200×200×150 µm. Crystals were directly flash frozen in liquid nitrogen. Crystallographic data were collected at 100 K using beam-line BLI911-3 (19) at MAX-lab, Lund, Sweden. Diffraction data were processed by the XDS program (20) , and the structure was determined by the molecular replacement method and refined as detailed in "Supplementary material". Data collection and refinement statistics are seen in Table 1 . Data was initially used to 2.0 Å resolution, based on a 2.0 I/σ(I) cut-off or better, but subsequently limited to 2.5 Å resolution based on R cryst and refinement statistics. A total of 91.8 % of the residues in the complex are in the favored region of the Ramachandran plot, 6.6 % in the allowed region and 1.4 % in the outlier region as calculated by the program RAMPAGE (21) . The outliers are R16 and D17 in PRLv2 and E45, C51 and P203 in PRLR-ECD of which all, except for C51, are situated in flexible regions. Coordinates for the PRLv2/PRLR-ECD structure have been deposited in the Protein Data Bank with the accession code XXXX.
Graphical representations of molecular structures were created by Pymol (22) .
Results
Three different experimental techniques, HX-MS, NMR spectroscopy and Xray crystallography, were applied to study the interaction between PRL variants and PRLR-ECD. Even though the crystal structure contains by far the most detailed information, the solution state techniques (HX-MS and NMR) provide measures of dynamic properties in solution in terms of NMR chemical shifts and amide proton exchange rates, which are modulated by receptor binding. Thus, HX-MS and NMR provide important complementary information in linking the free and bound states of the hormone.
HX-MS analyses of PRLv2 in the absence and presence of PRLR-ECD.
HX-MS is a sensitive method for probing protein structure and dynamics in solution. In particular, proteinprotein complex formation is readily detected by comparing deuterium incorporation in the absence and presence of ligand (23) . We investigated the hydrogen exchange profile of PRLv2 in the absence and presence of PRLR-ECD by monitoring 27 peptides, covering 90% of the primary sequence of PRLv2.
Receptor binding resulted in a pronounced decrease in exchange of several peptides of PRLv2 ( Figure 1A ). As PRLv2 exclusively binds PRLR-ECD via BS1, the regional reductions in exchange report on peptides that comprise or are conformationally linked to BS1. Decreased deuterium incorporation was primarily confined to peptides covering helix 1, helix 4 and with a particularly pronounced protection from exchange observed in peptides of the short helix 1" and the C-terminal C191-C199 segment ( Figure 1B) . Remarkably, the exchange of peptides covering helix 2 and 3 also exhibited moderate protection upon complex formation, however only after prolonged exchange (10.000-100.000 sec, Figure 1B ). This exchange behavior implies a ligand induced conformational stabilization occurring outside the binding interface (23) . We rule out binding of a second PRLR-ECD molecule at BS2 as an explanation for the altered exchange properties of the helix 2 and 3 residues because the effects were also observed without an excess of PRLR-ECD (data not shown). We conclude that the complex truly is of 1:1 stoichiometry.
Furthermore, we compared the exchange kinetics of PRLv2 with that of wtPRL, both in the absence of PRLR-ECD. The exchange profiles were largely identical, however, wtPRL showed significantly reduced exchange, relative to PRLv2, in a short segment (residues [16] [17] [18] [19] [20] [21] [22] of the N-terminal part of helix 1 (data not shown). This indicates that PRLv2 is destabilized in this region which is important for BS2.
NMR analyses of PRLv1 in the absence and presence of PRLR-ECD.
The solution structure of wtPRL determined by NMR spectroscopy was first reported by Keeler et al. (14) . However, the accuracy of the proposed structure was questioned and an improved model was established by Teilum et al. (15) N]PRLv1 under identical conditions. The resonance assignments served for calculation of chemical shift differences between back-bone amide protons in PRLv1 in the free and receptor bound states. The NMR data are presented in Figure 2A and compared with X-ray data in Figure 2B . Under the high pH and high temperature conditions applied, NMR signals for amide groups were absent in several flexible stretches of the polypeptide chain due to fast, base-catalyzed exchange of the amide protons. Save for I3 * , no amide resonances were observed for residues 1-15 in wtPRL (15) . This is also the case for PRLv1, both free and in complex with PRLR-ECD, which indicates that the intrinsically flexible N-terminus is not involved in or significantly influenced by BS1 binding. Also included in the NMR silent regions in PRLv1 are: a significant part of loop 1 between helix 1 and helix 2 (G47-K69), a part of the loop connecting helix 3 and helix 4 (S151-Q157), and two residues in the C-terminal segment (N196-N197). As shown in Figure 2A several residues, for which the amide proton signal is absent in the free state, display amide proton resonances in PRLv1 complexed with PRLR-ECD, indicating that these regions become shielded, structurally stabilized, or by some other means, protected from solvent exchange upon complex formation. Collectively, the observed changes in chemical shifts and amide proton exchange rates point particularly to two dynamic regions, I51-S57 and N197-C199, as being important for receptor interaction. Due to fast amide proton exchange in the free state, chemical shift differences are not available for K53, A54, N56, S57, C58, N196 and N197, but neighboring residues, in particular T52, I55, N198 and C199, exhibit strong perturbations. Of note, the back-bone amide proton of N56 appears in the complex markedly deshielded, exhibiting an unusual down field chemical shift of 10.4 ppm.
For a more direct mapping of the contact surface between PRLv1 and PRLR-ECD the NMR cross-saturation method (18) was applied. The data (not shown) confirmed the importance of the I51-S57 and C-terminal segments as suggested by the NMR chemical shift perturbation and HX-MS data.
Crystal structure of PRLv2 bound to PRLR-ECD. Hexagonally shaped crystals of the complex between PRLv2 and PRLR-ECD were obtained using the hanging drop method. The structure was determined by the molecular replacement method, and the overall crystal structure of the 1:1 complex is shown in Figure  3 . The secondary structural elements found in the crystal structure of receptor bound PRLv2 are similar to those of free PRLv3 (PDB 2Q98) (16) . Present are the characteristic four main α-helices, denoted helix 1-4 (residues L15-F40, Q77-V102, I112-Q136 and E161-I193, respectively) and connected by loops 1, 2 and 3. Similar to PRLv3, three short helices, helix 1', 1'' and 3' (residues H59-S62, K69-A72 and L153-L156, respectively), are present in loop 1 and loop 3. In the structure of the complex, an additional short helix segment is formed in the N-terminal part of loop 1 (I51-A54). Due to weak or absent electron density, part of the Nterminal segment of loop 1 (R43-R48), the short loop 2 (G104-E110), the N-terminal part of the long loop 3 (H138-E145) and C199 in PRLv2 have been omitted from the model of the complex. In contrast, for free PRLv3 the complete sequence was modeled into the electron density (16) . However, in the crystal structure of PRLv3 more than half of the residues (100) are within a 5Å distance of symmetry related molecules resulting in stabilization of the flexible loops. Loop stabilizing crystal packing interactions are less abundant for PRLv2 in the complex structure, and apparent differences in the flexibility of the loop-segments between the free and bound forms can be explained mainly by crystal packing effects. The structure of PRLR-ECD (Figure 3 ) reveals the characteristic tandem repeat of fibronectin type III modules, D1 and D2 (residues 1-98 and 104-210, respectively), connected by a short inter-domain linker (residues 99-103). The relative domain orientation is very similar to that observed for GHR-ECD in published 1:1 and 2:1 complexes with GH and variants, but distinctively different from that of PRLR-ECD in complex with GH (12) .
The surface that becomes buried at the interface between PRLv2 and PRLR-ECD covers an area of approximately 1200 Å 2 . Two essential tryptophan residues in PRLR-ECD, W72 R and W139 R , dock on PRLv2 in an extended hydrophobic groove lined by helix 4 and mini helix 1'' (Figure 4) . Besides the contact residues belonging to helix 1 (H27, H30, N31), helix 4 (H173, R176, R177, H180, K181, D183, N184, Y185, K187, L188, C191 and R192) and the C-terminal half of loop 1 (P66, E67, D68, K69, E70, A72 and Q73), additional contact regions are situated in the N-terminal part of loop 1, including I51, T52, A54, I55 and N56 ( Figure 5) , and in the C-terminus (N197, and N198).
Differences observed between the structures of free PRLv3 and PRLv2 bound to PRLR-ECD are displayed in Figure 2B . The two structures were superimposed based on Cα atoms in residues present in α-helical segments (r.m.s. difference of 0.54 Å for 108 Cα atoms). Evidently, the most prominent back-bone shifts are in the 49-57 loop segment, which in the free state appears largely unstructured and flexible, but in the complex becomes structured by specific receptor interactions involving residues I51, T52, I55 and N56 ( Figure 5 ). In the complex structure, A54-S57 forms a type II β-turn and the I51-A54 segment curls up in a α-helix (H1b). This structural arrangement exposes the side chains of I51 and I55 for hydrophobic interaction with Y94 R and I76 R on the receptor, and spatially presents N56 allowing for favorable receptor interactions by tight backbone and side chain hydrogen bonds with E43 R and G44 R ( Figure 5 ). In the context of comparing free and bound states of the hormones, it should be emphasized that the I51-S57 segment in the free form (represented by either the crystal or the NMR structure (PDB 2Q98 and 1RW5, respectively)) appears flexible and unstructured. In the crystal structure of PRLv3, the electron density corresponding to the I51-S57 segment is weak, and the ramachandran plot corresponding to 2Q98 reveals that residues K53, A54, I55 and N56 all appear in disallowed regions. Thus, 2Q98 may not accurately represent the peptide chain in this particular region, and a detailed atom-to-atom comparison of the I51-S57 segment in PRLv3 and in PRLv2 makes no sense. Accordingly, the r.m.s.d. values ( Figure 2B ) derived for residues present in this region should only be interpreted qualitatively. The electron density corresponding to the receptor interacting I51-S57 segment is well defined in the present structure of the complex. On the other hand, the immediate up-sequence segment appears highly flexible, particularly the R43-R48 stretch which was excluded from the X-ray derived model of PRLv2. The R43-R48 segment in the structure of PRLv3 appears well ordered, a difference which we, however, ascribe to stabilizing crystal contacts.
Data in Figure 2B imply that upon receptor binding large scale changes occur in the C-terminus, containing the C191-C199 disulfide bond. However, caution is required when interpreting these differences as both crystal structures exhibit structural irregularities in the C-termini. In the structure of PRLv3 the C191-C199 disulfide bond is absent, leaving C191 and C199 with free thiol groups outside disulfide bonding range (16) . Additionally, the spatial orientation of the C-terminus appears to be governed by interactions that are specific for the crystalline state, as C199 makes contact with a symmetry related molecule in the crystal (16) . Furthermore, the electron density corresponding to the N197-N198-C199 segment in PRLv3 is very weak. In contrast, the electron density in the complexed structure of PRLv2 is intense and well defined for the C-terminal segment including N198, but is completely absent for C199. The distance between N198 and C191 is perfectly compatible with the presence of a C191-C199 disulfide bond, and apart from the missing density there are no signs of structural damage. It was verified (mass spectrometry, data not shown) that the PRLv2 present in the solution, from which crystals of the complex were grown, was C-terminally intact. NMR chemical shifts recorded for Cβ atoms in cysteines carry diagnostic information with respect to the binding state (free thiol or disulfide bound) of the side chain sulphur atom (24) . For PRLv1 in solution the NMR data unambiguously demonstrate that the C-terminal disulfide bond remains intact for weeks in samples of both free and complexed PRLv1.
It is well documented that synchrotron radiation can induce specific chemical damage to proteins (25) , including both disulfide bond and main chain cleavage. Disulfide linkages were shown to differ substantially in their susceptibility towards radiation induced damage, and the C-terminal disulfide bond in PRL may represent a particularly sensitive example.
Discussion
Data from site directed mutagenesis (26) (27) (28) , identifying a set of PRL residues as being functionally important for receptor binding and activation, combined with the structural information represented by the NMR solution structure of free PRL, allowed Teilum et al. (15) to draw a tentative map at residue resolution of BS1. The bulk of the BS1 residues was mapped to the C-terminal part of helix 4 (Y169, H173, R176, R177, H180, K181, N184, Y185, K187, and L188), while fewer critical BS1 residues were implied to reside in helix 1 (H27, H30, F37) and in the C-terminal part of loop 1 (H59, P66 and K69). The binding interface found in the crystal structure of the PRLv2/PRLR-ECD complex is generally in accordance with that defined by Teilum et al. (15) , but includes additional contact residues in the N-terminal part of loop 1 and in the C-terminus of the sequence.
One part of the PRLv2 binding interface, comprising helix 1 and helix 4 residues, constitutes a relatively static and receptor complementary surface with a pre-shaped topology. For this part of BS1 only minor side chain adjustments are necessary to accommodate contact residues from the receptor chain, particularly W72 R and W139 R . Similar interactions involving W72 R and W139 R are essential in the binding of GH to PRLR-ECD, and the corresponding residues in GHR, W104 R and W169 R , are critically involved in binding GH, accounting for the majority of the free energy of receptor binding (29) . Most likely, the primary energetic driving force in the formation of the PRLv2/PRLR-ECD complex comes from hydrophobic interactions involving W72 R and W139 R , (Figure 4) . The other part of the PRLv2 binding interface, including loop 1 residues, appears considerably more plastic and acquires its final topology in the complex during the event of receptor binding.
The PRLv2/hPRL-ECD complex structure provides a rationale for most of the effects on receptor binding associated with the functionally important residues identified by mutagenesis studies (26) (27) (28) . Particularly strong effects were observed by mutating K69, R177 and K181. The K69 side chain is in the PRLv2/PRLR-ECD complex stacking with W139 R and is further engaged in a tight, five element ion pairing network comprising K66 R -E18 R -K69-D134 R -K136 R ( Figure 6A) . Similarly, R177 engages in complex ion and hydrogen bonding connectivities involving E43 R , T74 R and D96 R and a water molecule, Wa (Figure 3 and 6B). Such an interaction involving all three nitrogen atoms in the R177 side chain conforms with the observation that even the conservative R177K mutation in the bovine system reduces the binding affinity by 90% (28) . Finally, for K181 the hydrophobic part of its side chain stacks tightly with the tryptophan ring of the essential W72 R . The side chain amino group in K181 is not involved in receptor interaction, but hydrogen bonds intramolecularly with T65 and might have an additional function in tethering loop 1 to helix 4. Provided that the BS1 interface found in PRLv2 is identical to that of the wild type, the reduced BS1 binding affinity associated with some of the reported alanine mutants must be attributed to secondary effects, since the modified residues are not involved in direct contacts, i.e. are situated outside a 5 Å distance from receptor atoms. These functional residues include V23 and F37 in helix 1, H59 in loop 1 and Y169 situated in helix 4.
Since the efficacy of a PRL antagonist based on the principle of impaired BS2 binding is in part defined by the affinity ratio between BS1 and BS2 (30) a key element in optimizing such antagonists, besides achieving efficient BS2 inhibition, is the maturation of BS1 binding affinity. In this context, the S61A and Q73A mutations attracted our attention. All alanine mutants reported for the C58-Q74 segment, except for S61A and Q73A, exhibited impaired receptor affinity and lactogenic activity (26) , indicating to us that positions 61 and 73 could be potential targets for affinity optimization. The effect of the S61A mutation was reported to be a marginally, and probably insignificant, increased biological activity compared to wtPRL (26) . Surprisingly, we observe a robust two-fold increase in receptor binding affinity (data not shown) when substituting S61 with alanine in the PRL sequence. Using the crystal structure, a hypothesis explaining the increased affinity of S61A can be formulated. In the unbound form (PRLv3) the R177 side chain is tied up internally by ion pairing with D178 and further polar interactions involving T60, S61 and a water molecule (Wc) (Figure 7) . Wc is buried well below the protein surface, sandwiched between helix 4 and loop 1 and held in place by a polar interaction network including the side chains of R177, D178, the backbone and the side chain of H59 and the C58-C174 disulfide bond. Elimination of the hydrogen bonding capability of S61 by substitution with alanine is hypothesized to weaken or abolish the intramolecular binding of the R177 side chain. Following this line of argumentation, receptor binding is favored by reduction of the energy spent for reorientation of the R177 side chain required for its interaction with receptor residues E43 R , D96 R and T74 R (Figure 6 ). A corresponding buried water molecule is absent in PRLv2 in the complex structure implying that Wc present in the free form will have to be expelled upon binding. In the NMR derived solution structure (PDB 1RW5) of wtPRL, the R177 side chain is not tied up internally as it is in the crystal structure of PRLv3. However, no NOE derived distance is constraining the position of the R177 guanidinium group in the NMR structure, and adjustment of only the χ3 and χ4 angles of R177 places the Nη1 nitrogen at a distance of 3.1 Å from the carboxyl carbon of D178, optimally positioned for ion pairing (the corresponding distance in PRLv3 is 3.5 Å). Thus, the side chain conformation of R177 defined by 2Q98 might be significantly populated in solution also.
Tightly bound water molecules are commonly found in protein crystal structures, either associated on the surface or buried. Such structured water molecules can be important in stabilizing protein structures and facilitate protein-protein contacts (31) , as exemplified by the water (Wa) mediated receptor interaction of R177 in the present complex structure ( Figure  6B ). In total, three buried water molecules, including Wc, are present in PRLv3 (PDB 2Q98), and of these only one (Wb) is conserved in the PRLv2/PRLR-ECD structure. Wb is positioned between helix 1 and helix 4 ( Figure  3 ), below the BS1 surface, and held in place solely by its polar interactions via main chain atoms including the carbonyl oxygen of S26 and S179 and amide groups of H30 and D183. The influence of Wb on BS1 is not known, but its conservation in the complex structure implies that bridging of helix 1 and helix 4 by Wb might have an important stabilizing function. Thus, mutation of nearby residues could potentially affect BS1 binding indirectly by disrupting water binding. Notably, the structural rationale for the effects of mutating S179 (32) adjacent to Wb has not previously been adequately accounted for.
While the C-terminal part of loop 1 has been subject to a close mutational scrutiny (26) , its N-terminal part has received less attention. Removal of the C58-C174 disulfide bond, tethering loop 1 to helix 4, essentially eliminates binding (26) , and deletion of the amino acid sequence 41-52 (33) leads to a marked reduction in binding affinity, implying that the segment spanning the C-terminus of helix 1 and C58 is important for lactogenic activity. The present crystal structure demonstrates that residues (I51, T52, I55 and N56) situated in the N-terminal part of loop 1 are involved in receptor interaction and should be considered as belonging to BS1. Receptor-induced structuring of loop 1 in PRLv2 is similarly observed for GH. Thus, a single α-helical turn, denoted mini-helix 1, is stabilized in the hGH molecule when it binds to GHR-ECD (34) . In PRLv2 N56 is engaged in tight hydrogen bond interaction with receptor residues, both via main and side chain amides. Interestingly, we have shown, that N56 is the primary site of deamidation in the hPRL sequence and that mono-deamidated species (N56D mutants) exhibit markedly reduced receptor binding affinity (data not shown). This may have general implications for the design and development of PRL-analogues as pharmaceuticals. In particular, for protracted analogues designed to circulate in the blood stream for a prolonged period of time, inactivation by deamidation is an issue to consider.
The C-terminal disulfide bond breakage in the crystals of PRLv3 and probably in PRLv2/PRLR-ECD renders structural comparison of the C-terminal segments meaningless. For PRL free in solution, the Cterminus appears to be relatively dynamic, but reduction of back-bone amide proton exchange rates for C-terminal residues, observed by both NMR and HX-MS, demonstrate that the Cterminal segment becomes stabilized in the complex. Furthermore, marked cross-saturation effects were observed for the C-terminal cysteine demonstrating its intimate contact with the receptor chain.
It has been proposed (35) that PRL BS2 is functionally coupled to BS1 in such a fashion that receptor binding at BS1 increases the affinity at BS2 for a second receptor chain. Based on fluorescence resonance energy transfer (FRET) data, an allosteric coupling of BS1 and BS2, involving receptor induced conformational changes in PRL, was suggested (35) . However, no detailed molecular mechanism was formulated, and the extent to which PRL actually undergoes significant structural rearrangements when interacting with the receptor chain via BS1 has been a matter of some debate. In the GH-system, it has been demonstrated that BS1 and BS2 are allosterically coupled in the sense that mutations in BS1 can induce conformational changes in BS2 (36) . The recent publication of the crystal structure of the PRLR antagonist, PRLv3 (16) , in combination with the present determination of the receptor complexed structure of the closely related variant, PRLv2, provides a unique opportunity to scrutinize the structural rearrangements associated with receptor binding at BS1. However, when comparing free and receptor bound conformations using X-ray structures the effects of crystal packing effects need to be carefully considered. To distinguish structural changes induced by crystal packing effects from changes directly associated with receptor interaction, solution state techniques, such as HX-MS and NMR, can provide important information. Several residues distributed throughout the primary sequence of PRLv1 exhibit significant amide proton chemical shift changes upon binding to PRLR-ECD (Figure 2A ). Chemical shifts can be affected either directly by contacts with the receptor at the binding interface or by conformational changes induced by binding. The perturbations observed in the N-terminal part of helix 4, which is not part of BS1, are in accordance with the structural changes in the long overhanging loop 1 implied by the crystal structures of free PRLv3 and receptor bound PRLv2 ( Figure 2B ). The NMR data, thus, support that the structural changes in loop 1 observed in the X-ray data are genuinely receptor induced, and not related to crystal packing effects Based on structural analysis it was for GH suggested, and supported by mutagenesis data (37) , that a communication between BS1 and BS2 is transmitted by structural rearrangements through a contiguous hydrophobic motif comprising F44, L93, Y160, L163, and Y164. The corresponding residues in the PRL sequence are F50, L98, Y169, L172 and H173. Of these only F50 undergoes significant movements upon receptor interaction, whereas only subtle changes are observed for L98, Y169, L172 and H173. This implies that such a mechanism is most probably not operational in the PRL molecule
As discussed above, receptor interaction of PRLv2 at BS1 induces part of the first loop to undergo large scale back-bone movements, which appear to influence the stability of the Cterminal turn of helix 1. However, as evident from Figure 2B , the relative position of the fourhelix bundle back-bone, including helix 3 harboring critical determinants of BS2 binding, remains essentially unaffected by BS1 binding. This is also reflected in the insignificant NMR chemical shift perturbations of helix 3 residues induced by receptor interaction (Figure 2A) . Thus, structural comparison of the free and bound states provides no evidence for an allosteric coupling of BS1 and BS2 in the G129R mutants. It is interesting, however, that the HX-MS data imply that receptor binding at BS1 modulate the back-bone dynamics of the helix bundle including helix 2 and 3, which are located on the opposite side of the cytokine from BS1 and in part harbor BS2. Recently it was suggested that the intrinsic dynamic properties associated with PRL are essential for its ability to elicit a fully functional response through PRLR (16) .
As shown by HX-MS comparison of free PRLv2 and free wtPRL, the N-terminal half of helix 1 in PRLv2 appears significantly destabilized relative to wtPRL, most likely as a consequence of the N-terminal deletion. This destabilization could be a major contributing factor to the attainment of full antagonistic properties of N-terminally deleted G129R-PRLvariants. The influence of the dynamic properties of PRL variants on their receptor binding characteristics deserves further experimental investigation.
In summary, we have determined the crystal structure of a PRL variant bound to PRLR-ECD, the first structure reported for a PRL molecule bound to its cognate receptor. Additionally, we have characterized the PRL/PRLR-ECD interaction in liquid state using HX-MS and NMR, providing important insights in the solution structure and dynamics. The presented data adds important information to the structural characterization of the PRL-system, improving the basis for further rational design and development of novel PRL-molecules. Important BS1 contact residues. (A) K69 is stacking with W139 R and is part of an ion pairing network comprising K66 R -E18 R -K69-D134 R -K136 R . Coloring is according to Figure 3. (B) R177 engages in complex ion and hydrogen bonding connectivities involving E43 R , T74 R and D96 R and a water molecule (Wa).
Figure 7
Rationale for the effects of S61A. PRLv3 (PDB 2Q98) is shown in gray cartoon representation with the side chains of C58, T60, S61, T60, C174, R177 and D178 represented by green sticks. The tightly bound water molecule, Wc, is shown as a magenta sphere. The side chain of R177 in PRLR-ECD bound PRLv2, superimposed on PRLv3, is represented by cyan sticks. 
